Wednesday, March 12, 2025 8:37:52 AM
Like to see some insider buying instead of handing out shares like candy through inducement grants these guys sold all there core assets it looks like a set up for a merger that will not be benefit investors Dillly or his VP have not engaged in insider Buying.
Cash Flow Statement
Operating Cash Flow (ttm) -49.41M
Levered Free Cash Flow (ttm) -29.93M
Not good these guys have so much competition remember CEO stated that 30% of the presentations at the conference where on enymatic manufacturing he even said its easy you just need a few pieces of hardware I mean anyone can do this. Holding my shares will not buy anymore Dilly is not doing a good job.
$CDXS
Cash Flow Statement
Operating Cash Flow (ttm) -49.41M
Levered Free Cash Flow (ttm) -29.93M
Not good these guys have so much competition remember CEO stated that 30% of the presentations at the conference where on enymatic manufacturing he even said its easy you just need a few pieces of hardware I mean anyone can do this. Holding my shares will not buy anymore Dilly is not doing a good job.
$CDXS
Recent CDXS News
- Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results • GlobeNewswire Inc. • 03/11/2026 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/11/2026 06:59:09 PM
- Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform • PR Newswire (US) • 03/04/2026 03:09:00 PM
- Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform • PR Newswire (US) • 03/04/2026 03:06:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:54:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:53:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2026 12:53:07 AM
- Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 • GlobeNewswire Inc. • 02/25/2026 02:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2026 01:08:57 AM
- Codexis to Participate in TD Cowen 46th Annual Health Care Conference • GlobeNewswire Inc. • 02/17/2026 02:00:00 PM
- Codexis Achieves ISO 9001:2015 Certification • GlobeNewswire Inc. • 02/10/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:07:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:06:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2026 11:18:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2026 11:15:57 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/23/2026 09:05:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/16/2026 10:09:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2026 11:51:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/08/2026 02:17:55 AM
- Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics • PR Newswire (US) • 01/07/2026 02:00:00 PM
- Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics • PR Newswire (US) • 01/07/2026 02:00:00 PM
